Impact of Sumac on postprandial high-fat oxidative stress

Pakistan Journal of Medical Sciences

Volumn 29, Issue 1 SUPPL., 2013, Pages 340-345

  Madihi, Yahya ^a   Merrikhi, Alireza ^a   Baradaran, Azar ^b   Rafieian Kopaei, Mahmoud ^c   Shahinfard, Najmeh ^c   Ansari, Roya ^c   Shirzad, Hedayatollah ^c   Mesripour, Azadeh ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atherosclerosis; Lipid metabolism; Traditional medicine

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTHOCYANIN; APOLIPOPROTEIN B; ASPARTATE AMINOTRANSFERASE; BLOOD CLOTTING FACTOR 7; CHOLESTEROL; FIBRINOGEN; GLUCOSE; HERBACEOUS AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; NITRITE; TRIACYLGLYCEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; DRUG ACTIVITY; DRUG EFFECT; EXPERIMENTAL RABBIT; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HYPERCHOLESTEROLEMIA; HYPOLIPIDEMIC ACTIVITY; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; MEDICINAL PLANT; NONHUMAN; OXIDATIVE STRESS; PHYSICAL CHEMISTRY; PHYTOCHEMISTRY; POSTPRANDIAL STATE; RHUS CORIARIA; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84874753776     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: 10.12669/pjms.291(Suppl).3529     Document Type: Article

References (55)

1. Slyper A. A fresh look at the atherogenic remnant hypothesis. Lancet. 1992;8814:289-291.
2. Sahni N, Gupta KL. Dietary antioxidents and oxidative stress in predialysis chronic kidney disease patients. J Nephropathology. 2012;1(3):134-142.
3. Ross R. The pathogenesis of atherosclerosis a perspective for the 1990's. Nature. 2002;6423:801-809.
4. Tavafi M. Diabetic nephropathy and antioxidants. J Nephropathology. 2013;2(1):20-27.
5. Candan F, Sokmen A. Effects of Rhus coriaria L (Anacardiaceae) on lipid peroxidation and free radical scavenging activity. Phytother Res. 2004;18:84-86.
6. Ozcan M. Antioxidant activities of rosemary, sage and sumac extracts and their combinations on stability of natural peanut oil. J Med Food. 2003;6(3):267-270
7. Kosar M, Bozan B, Temelli F, Baser KHC. Antioxidant activity and phenolic composition of sumac (Rhus coriaria L.) extracts. Food Chem. 2006;103(2):952-959.
8. Tolouian R, Hernandez GT. Prediction of Diabetic Nephropathy: The need for a sweet biomarker. J Nephropathology. 2013;2(1):4-5.
9. Rouhi H, Ganji F. Effect of N-acetyl cysteine on serum Lipoprotein (a) and proteinuria in type 2 diabetic patients. J Nephropathology. 2013;2(1):61-66.
10. Rayne S, Mazza G. Biological activities of extracts from sumac (Rhus Spp): a review. Plant Foods for Human Nutr. 2007;62(4):165-175.
11. Marcela C, Kamaran A, Adriana K, Ľubica Ch. Effect of sumac on cholesterol and triglycerides content of rabbits. Biochem. Behave. 2006;84(2):229-234.
12. Seerum ND. Cyclooxygenas inhibitory and antioxidant cyaniding glycosides in cherries and berries. Phytomed. 2001;8(5):362-369.
13. Mtach MD. Inhibition of matrix metalloproteinase activity in human prostate cancer cells by flavino fram lowbush blueberry. J Nutr Biochem. 2006;17(2):117-125.
14. Barros D. Behavioral and genoprotective effects of Vaccinium berries intake in mice. Pharmacol. Biochem. Behav. 2006;84(2):229-234.
15. Rafieian-Kopaei M, Asgary S, Adelnia A, Setorki M, Khazaei M, Kazemi S, et al. The effects of cornelian cherry on atherosclerosis and atherogenic factors in hypercholesterolemic rabbits. J Med Plants Res. 2011;5(13):2670-2676.
16. Kadar A. Influence of anthocyanosid treatment on the cholesterol induced atherosclerosis in rabbit. Pario Arterielle. 1979;5(4):18-21.
17. Foster S. Billberry: food and medicine. The Herb Companion. 1997:68-69.
18. Rahimi Z. ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy. J Nephropathology. 2012;1(3):143-151.
19. Gheissari A, Hemmatzadeh S, Merrikhi A, Fadaei Tehrani S, Madihi Y. Chronic Kidney Disease in Children: A report from a tertiary care center over 11 years. J Nephropathology. 2012;1(3):177-182.
20. Kari J. Epidemiology of chronic kidney disease in children. J Nephropathology. 2012;1(3):162-163.
21. Baradaran A. Lipoprotein(a), type 2 diabetes and nephropathy; the mystery continues. J Nephropathology. 2012;1(3):126-129.
22. Jungner WG. Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid modifying therapy. J Int Med. 2004;11(11):188-205.
23. Hendriks HFJ, Veenstra J, Van Tol A, Groener JE, Schaafsma G. Moderate doses of alcoholic beverages with dinner and postprandial high density lipoprotein composition. Alcohol. 1998;33:403-410.
24. Diminno G, Manicini M. Measuring plasma fibrinogen to predict stroke and myocardial infraction. Eur J Epidemiol. 1992;8(1):88-91.
25. Gheissari A, Mehrasa P, Merrikhi A, Madihi Y. Acute kidney injury: A pediatric experience over 10 years at a tertiary care center. J Nephropathology. 2012;1(2):101-108.
26. Assadi F. The epidemic of pediatric chronic kidney disease: the danger of skepticism. J Nephropathology. 2012;1(2):61-64.
27. Gen-Sini G, Galio M. Hemostatic factors atherogenesis and atherosclerosis. Biomed. Pharmacother. 1996;4395(4):67-75.
28. Harisson D. Alterations of vasomotor regulation in atherosclerosis. Cardiovasc Drug Ther. 1995;1:55-63.
29. Francis FJ. Anthocyanins as food colors. New York Academic Press. 1982:181-207. www.Wikipedia.org/wiki/Anthocyanin
30. Shirzad H, Taji F, Rafieian-Kopaei M. Correlation between antioxidant activity of garlic extracts and WEHI164 fibrosarcoma tumor growth in BALB/c mice. J Med Food. 2011;14(9):969-974.
31. Daher C, Abou-khalil J, Baroody G. Effect of acute and chronic grape fruit, orange and pinapple juice intake on blood lipid profile in normolipidemic rat. Med Sci Monit. 2005;11(12):465-472.
32. Nematbakhsh M, Ashrafi F, Pezeshki Z, Fatahi Z, Kianpoor F, Sanei MH, et al. A histopathological study of nephrotoxicity, hepatoxicity or testicular toxicity: Which one is the first observation as side effect of Cisplatin-induced toxicity in animal model. J Nephropathology. 2012;1(3):190-193.
33. Bowen P, Borthankur G. Postprandial lipid oxidation and cardiovascular disease risk. Curr Atheroscler Rep. 2004;6(6):477-484.
34. Lee P, Prasad K. Suppression of oxidative stress as mechanism of reduction of hypercholesterolemic atherosclerosis by cyclooxygenase inhibitor. Int J Angiol. 2003;8(1):61-69.
35. Kraml P, Flalova L, Andel M. Hyperlipoproteinemia impairs endothelium dependent vasodilation. Physiol Res. 2004;53(5):471-480.
36. Zarban A, Malekaneh M, Najary MT. Evaluation of antioxidant properties of 28 medicinal plants. J Med Sci. 2004;11(2):5-13.
37. Lissin LW, Cooke JP. Phytoesterogen and cardiovascular of health. J Am Coll Cardiol. 2000;35(6):1403-1410.
38. Rajabian T, Fallah-hosseini H. Effect of fruit juice and pomegranate seed oil on blood lipid levels and progression of atherosclerosis in hypercholesterolemic rabbits. J Med Plants. 2007;7(5):93-104.
39. Nuraliev IN, Avezov GA. The efficacy of quercetin in alloxan diabetes. EKSP Klin Farmacol. 1992;55(1):42-44.
40. Kwon K, Murakami A, Tanaka T, Ohigasha H. Dietary rutin but not its glycon quercetin ameliorates dextran sulfate sodium induced experimental colitis in mice: attenuation of pro-inflammatory gene expression. Biochem Pharmacol. 2005;69(3):395-400.
41. Teissedre P, Landrult N. Wine phenolics: contribution to dietary intake and bioavailability. Basic Life Sci. 1999;66:725-737.
42. Juhel C, Armand M, Pafumi Y, Vandermander J, Lairan D. Green tea extract (AR25) inhibits lypolisis of triglycerides in gastric and duodenal median, in vitro. J Nutr Biochem. 2000;11(1):45-51.
43. Wilcox J, Subramanian R, Sundell C, Tracey W, Pollock J, Harrison D Marsden. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol 1997;17(11):2479-2488.
44. Noto D, Barbagallo C, Cefalu A. Factor VII activity is an independent predictor of cardiovascular mortality in elderly women of a Sicilian population: results of an 11 year follow-up. Thromb. Haemost. 2007;87(2):206-210.
45. Roitman EV. Azizova OA, Amorozoa YA, Aseichev AV. Effect of oxidized fibrinogens on blood coagulation. Bull. Exp. Biol. Med. 2007;138(3):245-247.
46. Solati M, Mahboobi HR. Paraoxonase enzyme activity and dyslipidemia in chronic kidney disease patients. J Nephropathology. 2012;1(3):123-125.
47. Schoene NW, Guidry CA. Dietary soy isoflavones inhibit activation of rat platelets. J Nutr Biochem. 1999;10(7):421-426.
48. Grenett H, Abouagag L, Parks D, Booyse F. Ethanol and polyphenols (cat, quer) increase expression of fibrinolytic protein mRNA invivo in aortic endothelium. Biol Res. 2004;38(2):42-45.
49. Vaisanen S, Rankinen T, Penttila I, Rauramaa R. Factor VII coagulant activity in relation to serum lipoproteins and dietary fat in middle-aged men. Thromb. Haemostasis 2007;73(3):435-438.
50. Charlton M, Sreekumar R, Rasmussen D, Lindor K, Nair K. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology. 2002;35(4):898-904.
51. Naderi Gh, Asgary S, Gharipour M, Taher M, Khosravi E. Antioxidant effect of Piper nigrum on hepatocyte membrane and LDL oxidation and nonenzymatic glycosylation of hemoglobin-number. Hakim. 2008;10(4):11-16.
52. Okopien B, Krisiak R, Madej A, Belowski D, Zielinski M, Kowalski J. Effect of simvastatin and fluvastatin on plasma fibrinogen levels in patients with primary hypercholesterolemia. Polish J. Pharmacol. 2004;56(6):781-790.
53. Kotani K, Tsuzaki K, Taniguchi N, Sakane N. LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients. Int J Prev Med. 2012;3(3):160-166.
54. Askari G, Ghiasvand R, Feizi A, Ghanadian SM, Karimian J. The effect of quercetin supplementation on selected markers of infammation and oxidative stress. J Res Med Sci. 2012;17:637-641.
55. Ghyasi R, Sepehri G, Mohammadi M, Badalzadeh R, Ghyasi A. Effect of mebudipine on oxidative stress and lipid peroxidation in myocardial ischemic-reperfusion injury in male rat. J Res Med Sci. 2012;17(12)